A comparative study of the incidence of aseptic meningitis in symptomatic natural mumps patients and monovalent mumps vaccine recipients in Japan

Vaccine

Volumn 25, Issue 14, 2007, Pages 2742-2747

  Nagai, Takao ^a   Okafuji, Teruo ^a   Miyazaki, Chiaki ^a   Ito, Yuhei ^a   Kamada, Makoto ^a   Kumagai, Takuji ^a   Yuri, Kenji ^a   Sakiyama, Hiroshi ^a   Miyata, Akiko ^a   Ihara, Toshiaki ^a   Ochiai, Hitoshi ^a   Shimomura, Kunihisa ^a   Suzuki, Eitaro ^a   Torigoe, Sadayoshi ^a   Igarashi, Masahiro ^a   Kase, Tetsuo ^b   Okuno, Yoshinobu ^b   Nakayama, Tetsuo ^c  

^a Vaccine Study Group   (Japan)

^b OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Aseptic meningitis; Mumps vaccine; Natural mumps

Indexed keywords

MUMPS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ASEPTIC MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; MUMPS; MUMPS VIRUS; PEDIATRICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALIVA ANALYSIS; VIRUS DETECTION; VIRUS GENOME; VIRUS ISOLATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; JAPAN; MALE; MENINGITIS, ASEPTIC; MUMPS; MUMPS VACCINE; PROSPECTIVE STUDIES;

EID: 33947175547     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.11.068     Document Type: Article

References (25)

1. Katz S.L., Gershon A.A., and Hotez P.J. Krugman's infectious diseases of children. 10th ed. (1998), Mosby-Year Book, Inc., St. Louis, MO pp. 280-9
2. Carbone K.M., and Wolinsky J.S. Mumps virus. Fields virology. 4th ed. (2001), Williams & Wilkins, Philadelphia, PA pp. 1381-400
3. Peltola H., Heinonen O.P., Valle M., Paunio M., Virtanen M., Karanko V., et al. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 331 (1994) 1397-1402
4. Centers for Disease Control and Prevention. Measles, mumps, rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 47 RR-8 (1998) 1-60
5. Sugiura A., and Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J 10 (1991) 209-213
6. Ueda K., Miyazaki C., Hidaka Y., Okada K., Kusuhara K., and Kadoya R. Aseptic meningitis caused by measles-mumps-rubella vaccine in Japan. Lancet 346 (1995) 701-702
7. Infectious Disease Surveillance Center, National Institute of Infectious Diseases. Mumps, Japan, 1993-2002. IASR 2003;24:1-2.
8. Kashiwagi Y., Kawashima H., Takekuma K., Hoshika A., Mori T., and Nakayama T. Detection of mumps virus genome directly from clinical samples and a simple method for genetic differentiation of the Hoshino vaccine strain from wild strains of mumps virus. J Med Virol 52 (1997) 195-199
9. Chiba Y., Horino K., Umetsu M., Wataya Y., and Chiba S. Virus excretion and antibody response in saliva in natural mumps. Tohoku J Exp Med 111 (1973) 229-238
10. Yamada A., Takeuchi K., Tanabayashi K., Hishiyama M., and Sugiura A. Sequence variation of the P gene among mumps virus strains. Virology 172 (1989) 374-376
11. Yamada A., Takeuchi K., Tanabayashi K., Hishiyama M., Takahashi Y., and Sugiura A. Differentiation of the mumps vaccine strains from the wild viruses by the nucleotide sequences of the P gene. Vaccine 8 (1990) 553-557
12. Kashiwagi Y., Takami T., Mori T., and Nakayama T. Sequence analysis of F, SH, and HN genes among mumps virus strains in Japan. Arch Virol 144 (1999) 593-599
13. Takahashi M., Nakayama T., Kashiwagi Y., Takami T., Sonoda S., Yamanaka T., et al. Single genotype of measles virus is dominant whereas several genotypes of mumps virus are co-circulating. J Med Virol 62 (2000) 278-285
14. Inou Y., Nakayama T., Yoshida N., Uejima H., Yuri K., Kamada M., et al. Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes. J Med Virol 73 (2004) 97-104
15. Nakayama T., Oka S., Komase K., Mori T., Nakagawa M., Sasaki K., et al. The relationship between the mumps vaccine strain and parotitis after vaccination. J Infect Dis 165 (1992) 186-187
16. Katayama K., Oya A., Tanabayashi K., Okazaki K., Hishiyama M., Yamazaki S., et al. Differentiation of mumps vaccine strains from wild viruses by single-strand conformation polymorphism for the P gene. Vaccine 71 (1993) 621-623
17. Kimura M., Kuno-Sakai H., Yamazaki S., Yamada A., Hishiyama M., Kamiya H., et al. Adverse events associated with MMR vaccines in Japan. Acta Paediatr Jpn 38 (1996) 205-211
18. Philip R.N., Reinhard K.R., and Lachman D.B. Observations on a mumps epidemic in a virgin population. Am J Hyg 69 (1959) 91-111
19. Editorial. Mumps meningitis and MMR vaccination. Lancet 2 (1989) 1015-1016
20. Fescharek R., Quast U., Maass G., Merkle W., and Schwarz S. Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects. Vaccine 8 (1990) 446-456
21. WHO Expert Committee on Biological Standardization Requirements for mumps vaccine (LIVE). WHO Technical Report Series. 1987;760:139-64.
22. Yamanishi K., Takahashi M., Kurimura T., Ueda S., and Minekawa Y. Studies on live mumps virus vaccine. III. Evaluation of newly developed live mumps virus vaccine. Biken J 13 (1970) 157-161
23. Furesz J., and Contreras G. Vaccine-related mumps meningitis-Canada. Can Dis Wkly Rep 16 (1990) 253-254
24. Rebiere I., and Galy-Eyraud C. Estimation of the risk of aseptic meningitis associated with mumps vaccination, France 1991-1993. Int J Epidemiol 24 (1995) 1223-1227
25. Miller E., Goldacre M., Pugh S., Colville A., Farrington P., Flower A., et al. Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children. Lancet 341 (1993) 979-982